Skip to main content

Biocept Inc

BIOCDelisted Nov 20, 2023
Industry
Services-Medical Laboratories
SEC CIK
0001044378

Biocept Inc was delisted on Nov 20, 2023; its insiders filed their last Form 4 on Nov 18, 2022; 26 institutions reported holding it in 13F filings for Q1 2023, worth $304.2K in total; no superinvestor held it.

Key figures

Insider buys
0
Open market, last 90 days
Insider sells
0
Open market, last 90 days
13F holders
26
Q1 2023, 0 vs. previous quarter
13F value
$304.2K
Reported value at the end of Q1 2023
Superinvestors holding
0
At the end of Q1 2023

Superinvestors holding BIOC, Q1 2023

Go to the superinvestors tab

No superinvestor reported holding BIOC at the end of Q1 2023.

Latest insider trades

Open-market purchases and sales by Biocept Inc insiders from Form 4, newest first.

See all insider trades
Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 10, 2021 (view filing)Dec 91 dayHale David FDirectorSSale−374$4.06−$1.52K−78.7%101 after2 lots
Dec 10, 2021 (view filing)Dec 91 dayHale David FDirectorSSale−71$4.07−$288.97−8.2%796 after

Top 10 13F holders, Q1 2023

The largest institutional positions in Biocept Inc at the end of Q1 2023; share changes are against Q4 2022.

See all 26 holders
Institutions holding BIOC in Q1 2023
InstitutionSharesValue% of portfolioChange in sharesAction
Renaissance Technologies LLC193,741$66.0K0.00%+31,441+19.4%Added
BlackRock Inc.157,913$53.7K0.00%00.0%Unchanged
Geode Capital Management, LLC134,112$45.6K0.00%−3,386−2.5%Reduced
Bridgeway Capital Management, LLC94,200$32.0K0.00%−15,236−13.9%Reduced
HRT Financial LP55,334$18.0K0.00%+55,334New
State Street Corp40,596$13.8K0.00%00.0%Unchanged
Sabby Management, LLC29,602$10.1K0.04%−900−3.0%Reduced
Northern Trust Corp26,818$9.12K0.00%00.0%Unchanged
Taylor & Morgan Wealth Management, LLC26,000$8.84K0.01%00.0%Unchanged
Jane Street Group, LLC25,403$8.64K0.00%+25,403New